Amarin Corp Plcuk (AMRN) Operating Margin (QoQ) (2013 - 2026)

Amarin Corp Plcuk (AMRN) Operating Margin (QoQ) (2013 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn
10 Amarin Corp Plcuk 5.84 Bn 5.66 Bn 17.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9,588.00
Dec 31, 2025 9,312.00
Sep 30, 2025 -38.00
Jun 30, 2025 1,790.00
Mar 31, 2025 -7,194.00
Dec 31, 2024 9,156.00
Sep 30, 2024 -5,873.00
Jun 30, 2024 2,326.00
Mar 31, 2024 -9,006.00
Dec 31, 2023 9,850.00
Sep 30, 2023 -259.00
Jun 30, 2023 -972.00
Mar 31, 2023 -955.00
Dec 31, 2022 -490.00
Sep 30, 2022 6,081.00
Jun 30, 2022 -3,662.00
Mar 31, 2022 -3,576.00
Dec 31, 2021 1,505.00
Sep 30, 2021 -1,488.00
Jun 30, 2021 661.00